Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 27.60
-0.20 (-0.72%)
At close: Sep 18, 2026
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.44 billion as of September 18, 2026. Its market cap has increased by 1.14% in one year.
Market Cap
1.44B
Enterprise Value
1.05B
Revenue
377.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
€27.60
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from 1.49B to 1.44B, a decrease of -3.75%. That is a compound annual growth rate of -0.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.44B | -3.80% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 84.00M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.88M |
| Vidac Pharma Holding | 21.94M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 280.02K |